← Back to Search

Treatment for Chronic Obstructive Pulmonary Disease (BLOCK2 Trial)

N/A
Waitlist Available
Led By Stephen Lazarus, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

The study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and COPD to determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to characterize the phenotypic expression and severity of their underlying lung disease. Patients with will be identified via the EMR. 571 participants will be enrolled.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Characterize the phenotypic expression and severity of underlying lung disease.
Prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI)
Secondary study objectives
Association between beta-blocker use at discharge and cardiopulmonary outcomes in patients with COPD and AMI.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,420 Previous Clinical Trials
1,617,618 Total Patients Enrolled
United States Department of DefenseFED
904 Previous Clinical Trials
332,645 Total Patients Enrolled
University of Alabama at BirminghamOTHER
1,635 Previous Clinical Trials
2,304,575 Total Patients Enrolled
~111 spots leftby Oct 2025